Analog Devices, Inc. today announced a low power, next-generation biopotential analog front end (AFE) which enables smaller, lighter, and less obtrusive cardiac monitoring devices with longer battery life. The AD8233 AFE is
Analog Devices, Inc. today announced a low power, next-generation biopotential analog front end (AFE) which enables smaller, lighter, and less obtrusive cardiac monitoring devices with longer battery life. The AD8233 AFE is